Featured Health Care Finance Health Care Reform Health Law Policy Judicial Opinions Laura Dolbow Medicare/Medicaid Patient Care Pharmaceuticals Public Health Reimbursement Merck Price Negotiation Lawsuit May Face Same Obstacles as 340B Takings Claims Read more: Merck Price Negotiation Lawsuit May Face Same Obstacles as 340B Takings Claims
Patient Care Pharmaceuticals Public Health Law Research Reimbursement Social Determinants of Health Many Hospitals Receiving Discounted Drugs May Not Offer Patients Pharmaceutical Assistance Read more: Many Hospitals Receiving Discounted Drugs May Not Offer Patients Pharmaceutical Assistance
Aaron S. Kesselheim Ameet Sarpatwari Empirical FDA Generic Drugs Insurance Intellectual Property International Medicare/Medicaid Pharmaceuticals PORTAL Round-Up Monthly Round-Up of What to Read on Pharma Law and Policy Read more: Monthly Round-Up of What to Read on Pharma Law and Policy
Affordable Care Act Bioethics Health Care Finance Health Law Policy Insurance Pharmaceuticals Public Health Reimbursement Sravya Chary Federal Court Halts Implementation of 340B Dispute Resolution Rule Read more: Federal Court Halts Implementation of 340B Dispute Resolution Rule
Health Care Finance Health Care Reform Health Law Policy Medicare/Medicaid Patient Care Pharmaceuticals Public Health Reimbursement Sravya Chary Ensuring 340B Discounts Trickle Down to Low-Income Patients Read more: Ensuring 340B Discounts Trickle Down to Low-Income Patients
Featured Health Care Finance Health Care Reform Health Law Policy Medicare/Medicaid Patient Care Pharmaceuticals Reimbursement Sravya Chary HHS’s 340B Advisory Opinion: Helpful or Harmful? Read more: HHS’s 340B Advisory Opinion: Helpful or Harmful?
Health Care Finance Health Law Policy Insurance Patient Care Pharmaceuticals Public Health Reimbursement Sravya Chary Cuts to 340B Drug Reimbursement May be Harmful During COVID-19 Read more: Cuts to 340B Drug Reimbursement May be Harmful During COVID-19
Health Care Finance Health Law Policy Influenza Patient Care Pharmaceuticals Public Health Race Resource Allocation Social Determinants of Health Sravya Chary Duplicate Discounts Threaten the 340B Program During COVID-19 Read more: Duplicate Discounts Threaten the 340B Program During COVID-19
Featured Health Care Finance Health Law Policy Patient Care Pharmaceuticals Public Health Race Resource Allocation Social Determinants of Health To Address COVID-19 Disparities, 340B Hospitals Need More Flexibility Read more: To Address COVID-19 Disparities, 340B Hospitals Need More Flexibility
Affordable Care Act FDA Judicial Opinions Medicare/Medicaid Pharmaceuticals Rachel Sachs PhRMA Sues HHS (Again) For Trying To Expand 340B Discounts To Orphan Drugs Read more: PhRMA Sues HHS (Again) For Trying To Expand 340B Discounts To Orphan Drugs